Serizawa H, Mäkelä T P, Conaway J W, Conaway R C, Weinberg R A, Young R A
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Massachusetts 02142.
Nature. 1995 Mar 16;374(6519):280-2. doi: 10.1038/374280a0.
The RNA polymerase II large subunit contains an essential carboxy-terminal domain (CTD) believed to be involved in the response to regulators during transcription initiation. The CTD is phosphorylated on a portion of RNA polymerase II molecules in vivo and it can be phosphorylated by the general transcription factor TFIIH in vitro. A highly purified TFIIH from rat liver has been described; this, like human and yeast TFIIH, contains associated CTD kinase and helicase activities. We report here that two polypeptides of the purified mammalian TFIIH are the MO15/Cdk7 kinase and cyclin H subunits of the Cdk-activating kinase Cak, previously identified as a positive regulator of Cdc2 and Cdk2. TFIIH and Cak preparations are each capable of phosphorylating recombinant CTD and recombinant Cdk2 proteins. The presence of Cak in TFIIH indicates that Cak may have roles in transcriptional regulation and in cell-cycle control.
RNA聚合酶II大亚基包含一个必需的羧基末端结构域(CTD),据信该结构域在转录起始过程中参与对调节因子的应答。在体内,CTD在一部分RNA聚合酶II分子上发生磷酸化,并且在体外它可被通用转录因子TFIIH磷酸化。已经描述了从大鼠肝脏中高度纯化的TFIIH;与人和酵母TFIIH一样,它含有相关的CTD激酶和解旋酶活性。我们在此报告,纯化的哺乳动物TFIIH的两种多肽是Cdk激活激酶Cak的MO15/Cdk7激酶和细胞周期蛋白H亚基,Cak先前被鉴定为Cdc2和Cdk2的正向调节因子。TFIIH制剂和Cak制剂各自都能够磷酸化重组CTD和重组Cdk2蛋白。TFIIH中存在Cak表明Cak可能在转录调控和细胞周期控制中发挥作用。